Accessibility Menu
 
Covalon Technologies logo

Covalon Technologies

(OTC) CVALF

Current Price$1.25
Market Cap$34.52M
Since IPO (2012)+122%
5 Year+7%
1 Year-16%
1 Month+7%

Covalon Technologies Financials at a Glance

Market Cap

$34.52M

Revenue (TTM)

$31.53M

Net Income (TTM)

$977.32K

EPS (TTM)

$0.03

P/E Ratio

49.21

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Price

$1.25

Volume

5,960

Open

$1.25

Previous Close

$1.25

Daily Range

$1.25 - $1.28

52-Week Range

$1.16 - $2.00

CVALF News

No articles available.

CVALF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Industry

Biotechnology

CEO

Brent Ashton

Headquarters

Mississauga, ON L4W 5S7, CA

CVALF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

2%

Net Income Margin

3%

Return on Equity

3%

Return on Capital

2%

Return on Assets

3%

Earnings Yield

2.03%

Dividend Yield

0.00%

Payout Ratio

4.24%

Stock Overview

Market Cap

$34.52M

Shares Outstanding

27.62M

Volume

5.96K

Short Interest

0.00%

Avg. Volume

8.25K

Financials (TTM)

Gross Profit

$17.47M

Operating Income

$1.76M

EBITDA

$2.72M

Operating Cash Flow

$1.64M

Capital Expenditure

$462.52K

Free Cash Flow

$1.18M

Cash & ST Invst.

$17.37M

Total Debt

$2.25M

Covalon Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$6.88M

-15.7%

Gross Profit

$3.80M

-23.8%

Gross Margin

55.27%

N/A

Market Cap

$34.52M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$125.27K

-89.6%

EBITDA

$294.52K

-81.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$14.27M

-14.6%

Accounts Receivable

$2.18M

-60.5%

Inventory

$6.82M

-20.5%

Long Term Debt

$3.07M

+1317.4%

Short Term Debt

$529.96K

-6.7%

Return on Assets

2.98%

N/A

Return on Invested Capital

1.79%

N/A

Free Cash Flow

$5.10M

+7638.3%

Operating Cash Flow

$5.75M

+4515.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SEOVFSernova Corp.
$0.11-0.61%
MMIRFMedMira Inc.
$0.05+239.10%
INNMFAmplia Therapeutics Limited
$0.08+0.00%
ACHFFArch Biopartners Inc.
$0.40-9.62%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
NVDANvidia
$172.70-0.03%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%

Questions About CVALF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.